Ad is loading...
FWWNX vs SBEMX
FWWNX vs SBEMX Comparison
Open Charts FWWNX vs SBEMX
American Funds New World 529-F-3
Price$81.31
Change+$0.21 (+0.26%)
VolumeN/A
Net Assets63.85B
Segall Bryant & Hamill Em Mkts Instl
Price$9.48
Change+$0.05 (+0.53%)
VolumeN/A
Net Assets66.66M
FWWNX vs SBEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
FWWNX has more cash in the bank: 63.8B vs. SBEMX (66.7M). SBEMX pays higher dividends than FWWNX: SBEMX (6.49) vs FWWNX (1.16). FWWNX was incepted earlier than SBEMX: FWWNX (5 years) vs SBEMX (14 years). SBEMX (1.99) is less costly to investors than FWWNX (0.63). SBEMX is a more actively managed with annual turnover of: 88.00 vs. FWWNX (37.00). FWWNX has a lower initial minimum investment than SBEMX: FWWNX (250) vs SBEMX (250000). SBEMX annual gain was more profitable for investors over the last year : 7.97 vs. FWWNX (3.66).
| FWWNX | SBEMX | FWWNX / SBEMX | |
| Total Expense Ratio | 0.63 | 1.23 | 51% |
| Annual Report Gross Expense Ratio | 0.63 | 1.99 | 32% |
| Fund Existence | 5 years | 14 years | - |
| Gain YTD | 6.080 | 5.568 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 63.8B | 66.7M | 95,652% |
| Annual Yield % from dividends | 1.16 | 6.49 | 18% |
| Returns for 1 year | 3.66 | 7.97 | 46% |
| Returns for 3 years | 28.15 | 37.33 | 75% |
| Returns for 5 years | N/A | 68.45 | - |
| Returns for 10 years | N/A | 53.87 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OBIIX | 9.96 | 0.09 | +0.91% |
| Oberweis International Opps Instl | |||
| FHEQX | 13.02 | 0.07 | +0.54% |
| Federated Hermes SDG Engagement Eq A | |||
| VITAX | 292.52 | -0.02 | -0.01% |
| Vanguard Information Technology Idx Adm | |||
| FTRNX | 163.45 | -0.09 | -0.06% |
| Fidelity Trend | |||
| ETNHX | 29.69 | -0.49 | -1.62% |
| Eventide Healthcare & Life Sciences N | |||